Global /China /Healthcare /Drug Manufacturers - General /600129

Chongqing Taiji Industry(Group) Co.,Ltd

600129

• SSE: 600129 • Delayed

15.56CNY 0%

2.30 USD

As of 17 June 2026, Chongqing Taiji Industry(Group) Co.,Ltd has a market cap of $1.27B USD, ranking #9407 globally and #2527 in China. It ranks #799 in the Healthcare sector, and #303 in the Drug Manufacturers - General industry.

Global Rank

9407

Country Rank

2527

Sector Rank

799

Industry Rank

303

Key Stats

Market Cap

$1.27BUSD

8.58B CNY

Enterprise Value

$1.92BUSD

12.98B CNY

Revenue (TTM)

$1.51BUSD

10.2B CNY

EBITDA (TTM)

$93.01MUSD

628.53M CNY

Net Income (TTM)

$16.52MUSD

111.65M CNY

EBITDA Margin

6.2%

Profit Margin

1.1%

PE Ratio

75.5

Forward PE

31.1

PS Ratio

0.8

PB Ratio

2.4

EV/EBITDA

18.1

Company Profile

Country (HQ)

China

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Zongbin Yu open_in_new

Employees

10,864

Founded

1979

Website

taiji.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
0%	-3.1%	-3.5%	-12%	-26%	-14%	-24%	-68%	3.6%

News

Markets

Exchange	Ticker	Price	Quotes
Shanghai Stock Exchange (SSE / SHA) MIC: XSHG PRIMARY	600129 重庆太极实业(集团)股份有限公司 Class A ISIN: CNE000000TQ2 Shares Out.: Shares Outstanding: 551.418M¹ Shares Float: 332.736M² TV: TradingView: SSE: 600129 SA: Stock Analysis: SHA: 600129 YF: Yahoo Finance: 600129.SS GF: Google Finance: SHA: 600129 BA: Barron's: 600129 MS: Morningstar: XSHG: 600129	15.56 CNY	TV: TradingView: SSE: 600129 SA: Stock Analysis: SHA: 600129 YF: Yahoo Finance: 600129.SS GF: Google Finance: SHA: 600129 BA: Barron's: 600129 MS: Morningstar: XSHG: 600129

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Chongqing Taiji Industry(Group) Co.,Ltd

Chongqing Taiji Industry(Group) Co.,Ltd, together with its subsidiaries, engages in the production and sales of Chinese and western medicine products in China and internationally. It operates through Pharmaceutical Industry; Pharmaceutical Business; Chinese medicinal materials Resources; Big Health and International; and Service Industry and Others segments. The company offers respiratory system, digestive system and metabolic, nervous system, cardiovascular and cerebrovascular, big health, anti-infective, anti-tumor, immunomodulatory drugs; and anti-aging products. It also engages in accommodation, loading and unloading, warehousing, catering, retail, agriculture, wholesale, and aquaculture activities; and research and development of medicinal herb planting. Chongqing Taiji Industry(Group) Co.,Ltd was incorporated in 1979 and is headquartered in Chongqing, China.

Similar Companies

Industry: Drug Manufacturers - General (China)

Name	Market Cap (USD) diff.	PE	Country
Jiangsu Hengrui Pharmaceuticals Co.,Ltd SSE: 600276	$54.0B 364.89B CNY 4K%	44.9	China
WuXi AppTec Co., Ltd. SSE: 603259	$49.78B 336.36B CNY 4K%	17.2	China
Hansoh Pharmaceutical Group Company Ltd. SHEK: 3692	$28.53B 223.48B HKD 2K%	35.7	China
Innovent Biologics, Inc. SHEK: 1801	$18.81B 147.32B HKD 1K%	162.3	China
Sichuan Biokin Pharmaceutical Co.,Ltd. SSE: 688506	$16.56B 111.89B CNY 1K%	-	China
Akeso, Inc. SHEK: 9926	$16.02B 125.46B HKD 1K%	-	China

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 60K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 43K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 28K%	97.4	United States
Roche Holding AG SIX: RO	$323.08B 256.25B CHF 25K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$289.5B 215.59B GBP 23K%	27.6	United Kingdom
Novartis AG SIX: NOVN	$275.99B 218.9B CHF 22K%	20.5	Switzerland

chevron_leftBack